Related by context. All words. (Click for frequent words.) 72 Receptor TLR 71 Receptors TLRs 69 Like Receptor TLR 68 Like Receptor 63 receptor TLR 60 free hotline #-#-CHICAGO 59 agonist compounds 59 receptors TLRs 56 Nasdaq IDRA 55 Receptors 53 Collection ETC 53 #-#-#-# s.archambault @ evolutiongrp.com 51 TLR8 agonists 51 Nasdaq IDRA today 51 TLR9 agonist 50 free #-#-# info@trilogy-capital.com 50 TLR9 agonists 50 QRX 49 Receptor Antagonist 49 House refrigerated prepackaged 49 prepackaged refrigerated cookie dough 47 activin receptor type 47 TLR3 agonist 47 oral inducer 47 TLR9 47 TLR Therapeutics 47 receptor agonists 46 Communications Ryon Harms 46 Receptor Antagonists 46 receptor signaling 46 immuno inflammatory diseases 46 Nasdaq ACHN 46 ProMune 45 TLR7 45 activate SIRT1 45 AMPK activators 45 protein kinase inhibitors 45 TBC M4 45 Receptor 45 tkRNAi 45 endogenous interferons 44 TLR7 agonist 44 novel peptide 44 Maxy G# 44 Catalyst Biosciences 44 THR beta agonist 44 SAR# [002] 44 Chemokine 44 TLR8 44 2 inhibitor CYT# 44 anticancer therapeutics 44 Initiates Enrollment 44 alpha 2A adrenergic 44 Idera Pharmaceuticals 43 Kinase Inhibitor 43 Idera Pharmaceuticals develops 43 TLR7 pathway 43 SMIP 43 Vegenics 43 Antibody 43 Initiates Clinical 43 Accelerated Intelligent 43 novel orally administered 43 Versartis 43 SinuNase ™ 43 IIB ActRIIB 43 Initiates Phase II 43 TLR9 agonist IMO 43 vascular disrupting agents 43 small molecule modulators 43 Presents Preclinical 43 mitotic kinesin 43 Begins Dosing 42 interferon lambda 42 adecatumumab MT# 42 HDAC Inhibitor 42 highly selective adenosine 42 Xanthus Pharmaceuticals Inc. 42 Reports Preclinical Data 42 small molecule inhibitors 42 Inc. Nasdaq MAXY 42 receptor agonist 42 Gamma secretase 42 midstage clinical 42 MT#/MEDI-# 42 non nucleoside inhibitor 42 vaccine adjuvants 42 OMP #R# 42 mGluR5 antagonists 42 Anticalin 42 HCV polymerase 42 seliciclib CYC# 42 tiapamil 42 PF # [002] 42 CB2 selective receptor agonist 42 Submits IND 42 proteasome inhibitor 42 IAP inhibitor 42 Adenosine Therapeutics 42 PI3 K 42 mGluR2 NAM 42 Completes Patient Enrollment 42 defensin mimetic antibiotic 42 anti amnesic 42 AFREZZA ® 42 TransVax tm 41 receptor ligands 41 small molecule 41 antibody fragment therapeutics 41 EZN 41 Archexin 41 histone deacetylase HDAC 41 Inotek Pharmaceuticals Corporation 41 Delta opioid receptor 41 peptibody 41 A3 adenosine receptor 41 ENMD # 41 selectin antagonist 41 therapeutic monoclonal antibody 41 infectious diseases autoimmune 41 Tesmilifene 41 small molecule inducer 41 JAK inhibitor 41 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 41 R roscovitine 41 Panzem NCD 41 VentiRx Pharmaceuticals 41 Protein Kinase C 41 adenosine A2A 41 RTP #i 41 PAION AG ISIN 41 Enzastaurin 41 Initiates Phase III 41 GPCR targets 41 receptor modulators 41 AFREZZA TM 41 IAP inhibitors 41 investigational humanized monoclonal antibody 41 cyclin dependent kinase CDK 41 OXIGON TM 41 potently inhibit 41 agonist 41 Therapeutic Competitors Companies 41 PDE4 41 mertansine 41 Initiates Phase 2b 41 Ceflatonin R 40 delta isoform 40 Presents Preclinical Data 40 psoriasis rheumatoid arthritis 40 TLRs 40 platform HDL Mimetic 40 OMP #M# 40 outlicensed 40 JAK1 40 PI3 Kinase 40 AKT inhibitor 40 IKK epsilon 40 ELND-#/AZD-# 40 brivanib 40 CCR1 40 HSP# inhibitors 40 vascular disrupting agent 40 ALN VSP Phase 40 targeted radiotherapeutic 40 aurora kinase 40 Inc. Nasdaq NEXM 40 drug GLPG# 40 selective kinase inhibitor 40 selective inhibition 40 CD# CEA 40 elotuzumab 40 potent anticancer 40 peroxisome proliferator activated 40 microsomal triglyceride transfer 40 M2 subunit 40 rxRNA 40 Initiates Clinical Trial 40 tubulin inhibitors 40 histone deacetylase 40 IGF 1R 40 Inc. Nasdaq MITI 40 Successfully Completes Phase 40 Xcytrin R 40 MKC# MT 40 thyroid hormone receptor 40 cholesteryl ester transfer 40 phosphatidylinositol 3 40 siRNA therapeutic 40 apoptosis proteins 40 Vascular Endothelial Growth 40 Ad5FGF 4 40 AtuRNAi 40 JAK inhibitors 40 Posiphen 40 bioactive lipids 40 AAG geldanamycin analog 40 KSP inhibitor 40 Files Investigational 40 Receptor Agonists 40 reversible inhibitor 40 Cathepsin S 40 deforolimus 40 JAK2 inhibitor 40 SynCon ™ DNA 40 IgG1 monoclonal antibody 40 targets Galectin receptors 40 kinase PI3K 40 engineered proteases 40 potent antiproliferative 40 OncoVex 40 Pertuzumab 40 Vilazodone 40 cathepsin K inhibitor 40 receptor partial agonist 40 VEGF receptor 40 humanized monoclonal 39 TLR8 agonist 39 IG HCR ;) CO 39 TKB# 39 isoform selective 39 Affilin ® 39 GSK '# 39 personalized dendritic 39 PSN# [001] 39 Aganocide ® 39 oral prodrug 39 immune stimulatory 39 PEG SN# 39 anti atherothrombotic 39 Tß4 39 PDX pralatrexate 39 Squalamine 39 secretory phospholipase A2 39 commercialize CorMedix drug 39 ALTROPANE R 39 initiated Phase Ib 39 Angiocept 39 MKC# MKC# PP 39 Y2 receptor 39 IMC #B 39 VaxInnate proprietary 39 sphingosine 1 39 FGFR 39 tramiprosate Alzhemed TM 39 radiation sensitizer 39 antibody MT# 39 Alvine Pharmaceuticals Inc. 39 ALS #-# 39 HSP# inhibitor 39 cyclin dependent kinase inhibitor 39 receptor PPAR 39 PSN# [002] 39 antibody trastuzumab 39 PDE# 39 compound PMX # 39 Alfacell proprietary ribonuclease 39 please visit http:/www.vandapharma.com 39 novel histone deacetylase 39 HepeX B TM 39 alpha#beta# 39 antiviral compounds 39 clinically validated targets 39 ribonucleotide reductase clinically validated 39 HGS ETR2 39 Annamycin 39 allosteric modulator 39 HuLuc# 39 Initiates Phase 39 receptor alpha 39 PANVAC VF 39 Anidulafungin 39 receptors PPARs 39 Present Preclinical Data 39 Small Molecule 39 MCSP respectively 39 Sphingomab 39 HepDirect 39 Nasdaq MITI biopharmaceutical 39 PENNVAX B 39 ASONEP ™ 39 chemokine 39 TNF á 39 Achieves Primary Endpoint 39 telomerase therapeutic 39 GPR# agonist 39 IMC A# 39 Tyrosine Kinase Inhibitor 39 Files IND 39 NS5b 39 alpha particle emitter thorium 39 Nanobody 39 oral kinase inhibitor 39 Humira adalimumab 38 receptor mediated 38 attach auristatin 38 Commences Phase 38 Telik logo TELINTRA 38 Cotara ® 38 agonists antagonists 38 Hsp# Inhibitor 38 RNA antagonists 38 thiazolides 38 Xanafide 38 5 HT6 receptor 38 mitogen activated ERK kinase 38 Lung Cancer Drug 38 Receives Milestone Payment 38 Factor VIIa 38 tyrosine kinase inhibitor 38 MMAE 38 PPARγ 38 osteolytic bone disease 38 5 HT4 receptor 38 SynCon TM DNA 38 molecular imaging radiopharmaceutical 38 anti botulism antibody 38 Stapled Peptide 38 B lymphocyte stimulator 38 protein kinase inhibitor 38 Onconase 38 Novel Oral 38 enhance ApoA 38 Evoltra ® 38 CD# monoclonal antibody 38 Daclizumab 38 highly selective inhibitor 38 AGS PSCA 38 targeted antifolate 38 novel therapeutic antibodies 38 anticancer compounds 38 SGLT2 inhibitor 38 orally dosed 38 multi kinase inhibitor 38 Homspera TM 38 SGLT inhibitors 38 nitric oxide donating prostaglandin 38 Leuprolide 38 GVAX R 38 HCV polymerase inhibitors 38 induces apoptosis 38 selective estrogen receptor modulator 38 Drug Discovery AIDD 38 TÎ ² 4 38 cyclin dependent kinases 38 volociximab 38 topoisomerase II inhibitor 38 beta 1a 38 SGLT2 38 oral immunomodulatory 38 p# MAP kinase 38 metaglidasen 38 taxane derivative 38 drug conjugates ADCs 38 VEGFR2 38 5 HT2A 38 Akt inhibitor 38 Trastuzumab DM1 38 AFRESA ® 38 sodium glucose transporter 38 Granulocyte Colony Stimulating Factor 38 refrigerated pastas 38 TLR4 38 penetrating peptides 38 alpha folate receptor 38 proprietary LNA 38 Receives Orphan Drug Designation 38 Tarmogen 38 motesanib diphosphate 38 SGLT 38 STEDESA 38 5 HT4 38 Pathway Inhibitor 38 PROfusion 38 novel immunotherapies 38 Kosan dependence 38 apricitabine ATC 38 anti CD3 monoclonal 38 PrevOnco 38 NK1 38 transient receptor 38 cytochrome P 38 Nasulin ™ 38 cytokine refractory 38 Universal Flu Vaccine 38 HyperAcute 38 Kythera Biopharmaceuticals 38 IMiD 38 Micromet proprietary BiTE 38 Rigel R# 38 Locked Nucleic Acid 38 biobetter 38 agonistic human 38 delipidation 38 MGd 37 hypoxia selective 37 epothilones 37 proteasome inhibitors 37 MDR1 37 neuropathic pain metabolic diseases 37 erlotinib Tarceva 37 GlycArt 37 Pazopanib 37 methionine aminopeptidase 37 Antibody Drug Conjugate 37 CD4 monoclonal antibody 37 Pharmos proprietary 37 Systemic Delivery 37 M# rationally 37 nicotinic acetylcholine receptor 37 sapacitabine CYC# 37 Cannabinoid 37 Pixantrone BBR 37 non nucleoside HCV 37 generation nucleoside analog 37 Nanobody R 37 nicotinic alpha 7 37 TLR3 37 Adnectin 37 Novavax VLP vaccine 37 intranasal formulation 37 NEUGENE antisense 37 microtubule inhibitor 37 Romidepsin 37 Aurora Kinase 37 TransVax ™ 37 JAK2 Inhibitor 37 Janus Kinase 37 JZP 37 Trubion proprietary 37 targeting CD# 37 antisense inhibitor 37 Luteinizing Hormone Releasing Hormone 37 PI3K inhibitor 37 candidate iSONEP TM 37 Solazed TM 37 histone deacetylase HDAC inhibitor 37 Locked Nucleic Acid LNA 37 C5aR 37 polysaccharide polymer 37 S#P# 37 HCV protease inhibitor 37 GVAX ® 37 ddRNAi 37 Ixabepilone 37 potent cytotoxic 37 virus HCV protease inhibitor 37 anti secretory 37 Darapladib 37 EnVivo Pharmaceuticals Inc. 37 Submits Biologics License Application 37 VEGFR 37 Talabostat 37 muscarinic 37 Antisense 37 candidate REP# 37 HepDirect prodrug 37 Receptor Agonist 37 PDE4 inhibitor 37 triciribine phosphate monohydrate 37 selectively inhibited 37 alpha#beta# integrin 37 oral antiviral 37 Tumor Necrosis Factor 37 Phase 2a Clinical Trial 37 drug conjugate 37 novel VDA molecule 37 Drug Candidate 37 polymerase inhibitors 37 monoclonal antibody mAb 37 NY ESO 37 Exherin 37 sulfonylhydrazine class 37 phosphoinositide 3 37 orally administered inhibitor 37 immunomodulatory 37 ispinesib SB # 37 methyl D aspartate 37 tumor vascular disrupting 37 PLK1 SNALP 37 inverse agonist 37 Vidaza R 37 Unit Dose Budesonide 37 secreted protein 37 lysophosphatidic acid LPA 37 HCV protease 37 agent bevasiranib 37 prodrugs 37 Immunotherapeutic 37 chimeric monoclonal antibody 37 Albuferon albinterferon alfa 2b 37 CORT # estimates 37 small molecule inhibitor 37 isotype 37 MEK inhibitor 37 gastrin analogue TT 37 Fibroblast Growth Factor Receptor 37 Azixa MPC 37 Protein Kinase 37 staphylococcal vaccines 37 Nexavar sorafenib 37 liposomal formulation 37 dasatinib Sprycel ® 37 Liposomal 37 HDAC 37 TLR antagonist 37 Multimeric 37 Preclinical studies suggest 37 short interfering RNA 36 thrombin receptor 36 bifunctional 36 selective antagonist 36 Sphingosine 1 36 using VIAdel TM 36 CB2 receptor selective 36 highly selective endothelin 36 inhaled formulation 36 NYSE Amex AEN 36 mitogen activated protein kinase 36 DNA intercalator 36 protein tyrosine kinase 36 humanized monoclonal antibodies 36 monoclonal antibody MAb 36 generation purine nucleoside 36 RAS MAPK pathway 36 5 HT2A receptor 36 myelofibrosis polycythemia vera 36 5 HT6 36 hyaluronidase enzyme 36 developing Zerenex ferric 36 trodusquemine MSI 36 selective inhibitor 36 thrombopoietin 36 PI3K/Akt pathway inhibitor 36 EGFR HER2 36 neuropathic pain spasticity 36 CYC# 36 YONDELIS 36 PNP inhibitor 36 Flt3 36 Monoclonal Antibody 36 vidofludimus 36 peptidomimetic 36 Omacetaxine 36 chemokine receptor 36 humanized therapeutic 36 humanized antibodies 36 OXi# 36 inhibit oxidative stress 36 IMiDs R 36 Epothilones 36 selective immunoproteasome inhibitor 36 targeted nucleotide prodrug 36 5 HT2A serotonin 36 protein CETP 36 selective modulator 36 Phase 2b Clinical Trial 36 DOS# 36 TRO# 36 Aptamer 36 poly ADP ribose polymerase 36 biased ligand 36 receptor tyrosine kinase inhibitor 36 effector function 36 directed radiotherapeutic antibody 36 Receives Approvable Letter 36 5 HT2C serotonin 36 potently inhibited 36 pan HDAC inhibitor 36 replicon 36 cMet 36 Aflibercept 36 Modrenal R 36 NPC 1C 36 Genotyping Test 36 Pharma Merck Serono 36 Prodrug 36 investigational protease inhibitor 36 GW# [003] 36 Phase 1b Clinical Trial 36 Orally administered 36 CRTH2 36 Aliskiren 36 Submits NDA 36 Pancreate 36 PEG irinotecan 36 pathophysiological effects 36 TRAIL Receptor 36 tyrosine kinase receptor 36 small molecule tyrosine 36 Aganocide 36 glycogen synthase kinase 36 Ep CAM 36 anaplastic lymphoma kinase 36 gastro intestinal inflammation 36 endogenous ligands 36 Dose Escalation 36 A2A receptor 36 Ecallantide 36 dependent cellular cytotoxicity 36 regorafenib 36 radiolabeled 36 Avian Influenza Vaccine 35 antidiabetic 35 cortisol synthesis 35 CYT# potent vascular disrupting 35 Meets Primary Endpoint 35 Darinaparsin 35 Initiate Phase 35 HCD# [002] 35 HDACi 35 Tumour Vascular Disrupting Agent 35 interleukin IL -# 35 Epidermal Growth Factor Receptor 35 peptidic compound 35 prostaglandin D2 35 investigational compounds 35 triggers apoptosis 35 nucleotide analog 35 tumor antigen 35 dopamine D2 35 neurokinin 1 35 triggers apoptosis programmed 35 AEG# 35 PKC isoforms 35 telomerase reverse transcriptase 35 pralatrexate injection folate analogue 35 Juvaris BioTherapeutics 35 oncolytic virus therapies 35 DEB# 35 candidate deforolimus 35 sphingosine kinase 35 albumin naturally occurring 35 Tesetaxel 35 LPA1 35 CYT# vascular disrupting 35 triple reuptake inhibitor 35 XOMA proprietary 35 related apoptosis inducing 35 deacetylase 35 small molecule thrombopoietin 35 oral Janus kinase 35 PORxin TM 35 IGF1R 35 humanized monoclonal antibody 35 reformulates existing FDA 35 anionic backbone 35 methyl CpG binding 35 CNS Disorders 35 EndoTAG 35 HER1 35 molecular therapeutics immunotherapies 35 Peroxisome Proliferator Activated Receptor 35 vemurafenib 35 novel orally bioavailable 35 delta opioid receptor 35 motexafin gadolinium Injection 35 #HT#A 35 Rindopepimut 35 small molecule macrocyclic 35 5 HT2A inverse 35 Glucagon Like Peptide 35 carbohydrate polymer 35 HQK 35 TNFα 35 TELINTRA R 35 Aplidin R 35 5 lipoxygenase 35 RON Notch 35 anthracycline derivative 35 metabotropic glutamate receptor 35 vinorelbine tartrate 35 ADP receptor antagonist 35 PEGylated 35 nucleoside analog 35 NU# direct 35 retinoic acid receptor 35 include Altastaph TM 35 humanized anti 35 nicotinic 35 Adenosine A2A 35 XL# anticancer compounds 35 #HT# 35 Fc fusion protein 35 cyclin dependent kinases CDKs 35 receptor inhibiting monoclonal 35 TRAIL receptor 35 MSCRAMM ® 35 immune modulatory 35 Fleximer 35 antibody cytokine 35 HCV RNA polymerase 35 oral JAK1 34 HER pathway 34 Cytotoxic 34 infectious diseases autoimmune diseases 34 commercializing oxidized glutathione 34 orally inhaled migraine 34 small molecule Hedgehog 34 selective A2A adenosine receptor 34 BRAF kinase 34 Merck OSI Pharmaceuticals 34 small molecule glucokinase 34 Enhanze TM Technology 34 selective adenosine 34 TLR agonists 34 humanized antibody 34 Kinase 34 cyclophilin inhibitors 34 metastatic colorectal 34 Sudhir Agrawal D.Phil 34 fusion enhancers 34 p# MAPK 34 Monoclonal 34 IMA# 34 benzimidazole 34 Plasmid DNA 34 Vaxfectin 34 BiTE 34 AFREZZA ™ 34 cytotoxic T lymphocyte 34 botulism antibody 34 polyketides 34 vesicular monoamine transporter 34 sodium glucose cotransporter 34 topical antifungal product 34 novel emulsion formulation 34 Tumor necrosis factor 34 staphylococcal vaccine 34 PKC# 34 selectively inhibit 34 peripherally restricted 34 receptor inhibitor 34 2A receptor agonist 34 Apoptone HE# 34 Saxagliptin 34 Factor Receptor 34 imatinib Gleevec ® 34 inhibitor COX 34 RAF kinase VEGFR 34 cytokines IL 34 Biogen Genentech 34 pan histone deacetylase 34 mda 7 34 lead molecular radiotherapeutic 34 partial agonist 34 ERK1 2 34 superoxide dismutase 34 thalidomide Thalomid 34 SynCon 34 Degarelix 34 Phosphodiesterase 34 synthetic peptide 34 Fludara ® 34 5HT 34 Voreloxin 34 immunostimulatory 34 cyclin dependent kinase 34 Panzem R 34 XOMA 3AB biodefense 34 Intravenous CP 34 including eniluracil ADH 34 PLK1 34 MKC# 34 protein tyrosine phosphatase 1B 34 immunotherapeutic 34 sorafenib Nexavar 34 accumulate preferentially 34 XOMA 3AB 34 Upregulation 34 Sphingomab TM 34 E#F# 34 NS5B polymerase 34 selective agonist 34 DepoVax TM 34 cyclooxygenase COX 34 reversible inhibitors 34 TNF alpha selectively neutralizing 34 MTP inhibitor 34 novel tubulin binding 34 IMiDs ® 33 Gammagard Liquid 33 N acetylgalactosamine 33 selective serotonin 2C receptor 33 oral anti arrhythmic 33 Epirubicin 33 ® bortezomib 33 cetuximab Erbitux R 33 oncolytic 33 kidney urologic 33 Randomized Phase 33 acting fibrinolytic 33 MT# MEDI 33 HuCAL antibody 33 R sorafenib tablets 33 gonadotrophin releasing hormone GnRH 33 kinesin spindle protein KSP 33 DNA methyltransferase inhibitors 33 transgenic mouse models 33 aurora kinase inhibitor 33 Olaparib 33 ALN PCS 33 DiLA2 33 Drug Shows Promise 33 antimitotic 33 Janus kinase 33 polyclonal antibody 33 Protease Inhibitor 33 humanized interleukin 6 33 introduced NEUGENE 33 epigenetic therapies 33 semi synthetic lipoglycopeptide 33 TO AVOID PREGNANCY WHILE 33 sunitinib Sutent ® 33 compound perifosine 33 PRN FDA Approves 33 inhibits plasma kallikrein 33 geldanamycin 33 potent suppressor 33 Muraglitazar 33 antisense compounds 33 includes TOLAMBA TM 33 RAV# 33 paclitaxel Taxol ® 33 myasthenia gravis Huntington 33 adrenoceptor agonist 33 MAb 33 CDDO Im 33 cell adhesion molecule 33 candidates Azedra TM 33 oral nucleoside analogue 33 IgG1 33 Recombinant Human 33 c myc gene 33 TLR2 33 RhuDex ® 33 recombinant antibodies 33 panitumumab Vectibix 33 lipid nanoparticle 33 Elacytarabine 32 Integrase 32 R bortezomib 32 Angiotensin 32 vitro pharmacology 32 alpha TNFa 32 Darinaparsin Zinapar TM 32 TRIOLEX HE# APOPTONE HE# 32 Thiarabine 32 FGFR3 32 Signaling Pathway 32 Long acting beta2 32 hepatitis C lupus 32 γ secretase 32 synthetic peptides 32 XP# XP# 32 serine proteases 32 lipopeptide 32 bevacizumab Avastin ® 32 factor Xa 32 dimebon latrepirdine 32 Anticancer Compound 32 Gleevec resistant 32 vinblastine 32 nilotinib Tasigna 32 Peroxisome proliferator activated 32 negative allosteric modulator 32 auristatin 32 Eg5 32 Histone Deacetylase 32 Zalypsis 32 signal transduction inhibitor 32 oral proteasome inhibitor 32 products MKC# PP 32 DP VPA 32 immune modulator 32 INxin TM 32 ,#,# [002] 32 polyglutamate 32 Adjuvanted 32 5 FU cytotoxic 32 irreversible inhibitor 32 Fibroblast Growth Factor 32 selective inverse agonist 32 DGAT 32 small molecule activators 32 alkylating 32 sublingual tablet formulation 32 dipeptidyl peptidase IV 32 ImmunoGen DM1 cancer 32 CXCR4 antagonist 31 Submits Supplemental 31 KRAS mutant 31 evaluating satraplatin 31 MET VEGFR2 31 Small Modular SMIP 31 5 HT2C 31 Temsirolimus 31 neuronal nicotinic receptor NNR 31 Angiotensin Converting Enzyme 31 PEGylated interferon 31 2 methoxyestradiol 31 includes ecallantide recombinant 31 anti miRs antisense oligonucleotide 31 TREANDA 31 anti CTLA 31 erlotinib Tarceva ® 31 selective phosphodiesterase 31 immunotoxin 31 HCV NS3 31 FLT3 31 Decitabine 31 Oral NKTR 31 CU NP 31 hepatoma 31 PrevOnco ™ 31 CDK cyclin dependent 31 herpes simplex viruses 31 Pivotal Phase 31 selectively binds 31 synthetic anti infective 31 Ganciclovir 31 receptor blocker 31 syngeneic 31 PDGFR B 31 MediGene focuses 31 Antigen Specific 31 xenograft models 31 Atripla combines 31 Maribavir 31 demonstrated antitumor activity 30 soluble tumor necrosis 30 potent inducer 30 AdVac ® 30 epoetin zeta 30 Antigenics QS 30 IL #R 30 systemic juvenile idiopathic 30 demethylating agent 30 regulated kinase 30 protein tyrosine phosphatases 30 somatostatin 30 PEGylated Fab fragment 30 Irinotecan 30 SPRYCEL ® 30 palonosetron hydrochloride Injection Dacogen 30 Imatinib mesylate 30 nucleoside analogues 30 lead compound ISA# 30 selective cannabinoid compounds 30 oral Factor Xa 30 VEGFR2 inhibitor 30 non porcine pancreatic 30 targets HGF FGFR 30 ChronVac C R 29 Vidaza ® 29 selective orally bioavailable 29 Nicotinic 29 adenovirus serotype 29 thrombopoietin TPO 29 proprietary BiTE ® 29 non thiazolidinedione TZD 29 cyclophosphamide methotrexate 29 alkylated amino acid 29 Pruvel TM 29 IMPDH inhibitor 29 drug monomethyl auristatin 29 Vytorin combines 29 certain protein tyrosine 29 treat refractory angina 29 Nedd4 29 quinoline 29 Quinamed R 29 5 FU leucovorin 29 Hepatocytes 29 Monopril 28 EOquin TM phase 28 delta gamma agonist 28 HIV treatments Reyataz 28 LymphoStat B belimumab 28 SGLT 2 28 actinin 28 Lenocta TM sodium stibogluconate 28 5 fluorouracil leucovorin 28 3TC lamivudine 28 folate analogue metabolic 27 Darinaparsin ZIO 27 Taxol ® 27 patented Aganocide compounds 27 using Crucell PER.C6 27 ErbB1 27 include Phenoptin TM 26 therapeutic peptide Thymosin 26 CYP#A# CYP#D# 26 Kosan proprietary 26 sapropterin dihydrochloride Phase 26 includes investigational compounds 26 Interferon alfa 26 inflammatory PDE 25 DPIV inhibitors